HPV Vaccine, Is It Really Harmful?

نویسنده

  • Sunghoon Kim
چکیده

which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Cervical cancer is considered a preventable disease because it has causative agent called Human Papilloma Virus (HPV). HPV infection was detected in up to 99% of women with squamous cell carcinoma of uterine cervix. Two HPV vaccines are approv­ ed by the U.S. Food and Drug Administration (FDA) and pro­ tect against subtypes 16 and 18. The first, GARDASIL ® , was li­ censed in 2006 and is now recommended as a routine vaccina­ tion for girls and women between the ages of 9­26 in the US. The second HPV vaccine, CERVARIX ® , was licensed in 2009. The World Health Organization (WHO) recommends the intro­ duction of HPV vaccination into national immunization pro­ grams (NIP) where prevention of cervical cancer is a public health priority and the introduction is programmatically feasible. However, until now, there are some doubts about the safety of HPV vaccine. For example, the claim that " HPV vaccines have an impressive safety profile is only supported by highly flawed design of safety trials and is contrary to accumulating evidence from vaccine safety surveillance databases and case reports which continue to link HPV vaccination to serious ad­ verse outcomes (including death and permanent disabilities) ". In June 2013, there were a few reports described as complex re­ gional pain syndrome (CRPS) and other chronic pain following HPV vaccination in Japan. After this issue, the safety of HPV vac­ cine rises to the surface again in Korea. Since the introduction of HPV vaccines in the US, adverse events related to the vaccination have been reported to US Ad­ verse Experience reporting system (VAERS). The most com­ mon events reported were: Syncope (or fainting)–common af­ ter injections. Of the 12,424 reports of adverse events, 772 (6% of all reports) described serious adverse events, including 32 reports of deaths, the remaining 11,652 (93.8%) were classified as non­serious. The 32 death reports were reviewed and there was no common pattern to the deaths that would suggest they were caused by the vaccine. In cases where there was an autopsy, death certificate, or medical records, the cause of death could be explained by factors other than the vaccine. Some causes of death determined to date include diabetes, viral illness, illicit drug use, and heart failure (1). US Vaccine Safety Datalink (VSD) active surveillance …

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran

HPV vaccine has been recently added to the Iran Drug List, so decision makers need information beyond that available from RCTs to recommend funding for this vaccination. Modeling and economic studies have addressed some of those information needs. We reviewed cost effectiveness studies to find a suitable model for Iranian population to determine the potential cost effectiveness of HPV vaccine p...

متن کامل

Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran

HPV vaccine has been recently added to the Iran Drug List, so decision makers need information beyond that available from RCTs to recommend funding for this vaccination. Modeling and economic studies have addressed some of those information needs. We reviewed cost effectiveness studies to find a suitable model for Iranian population to determine the potential cost effectiveness of HPV vaccine p...

متن کامل

Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran

Human Papilloma Virus (HPV) vaccine recently has been added to the Iran Drug List, decision makers need information beyond that available from RCTs to recommend funding for this vaccination program to add it to the National Immunization program in Iran. Modeling and economic studies have addressed some of those information needs in foreign countries. In order to determine the long term benefit ...

متن کامل

Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran

Human Papilloma Virus (HPV) vaccine recently has been added to the Iran Drug List, decision makers need information beyond that available from RCTs to recommend funding for this vaccination program to add it to the National Immunization program in Iran. Modeling and economic studies have addressed some of those information needs in foreign countries. In order to determine the long term benefit ...

متن کامل

A Step towards Resolving the Mystery of HPV Vaccination: Breakthrough of Cervical Cancer

HPVs (Human Papilloma virus) are associated with a variety of clinical conditions that ranges from less harmful lesions to life threatening cancer. During the onset of 19th century, HPV association with human cancers has been found with major links to genital warts and cervical cancers [1]. With recent advances in HPV vaccine, the possibility of preventing the second most common cancer among th...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 29  شماره 

صفحات  -

تاریخ انتشار 2014